Filtered By:
Specialty: International Medicine & Public Health
Condition: Multiple Sclerosis

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 33 results found since Jan 2013.

Prediction of driving ability in people with relapsing-remitting multiple sclerosis using the stroke driver screening assessment - Akinwuntan AE, O'Connor C, McGonegal E, Turchi K, Smith S, Williams M, Wachtel J.
In this study, we investigated the accuracy with which the Stroke Driver Screenin...
Source: SafetyLit: All (Unduplicated) - January 25, 2014 Category: Global & Universal Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Prediction of falls in subjects suffering from Parkinson's disease, multiple sclerosis and stroke - Beghi E, Gervasoni E, Pupillo E, Bianchi E, Montesano A, Aprile I, Agostini M, Rovaris M, Cattaneo D.
OBJECTIVE: To compare the risk of falls and fall predictors in patients with Parkinson's disease (PD), multiple sclerosis (MS) and stroke using the same study design. DESIGN: Multicenter prospective cohort study. SETTING: Three [masked] institution...
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Kessler Foundation receives New Jersey Health Foundation grants for MS and stroke research
(Kessler Foundation) Two Kessler Foundation scientists received grants from the New Jersey Health Foundation. Vikram Shenoy Handiru, PhD, received a one-year $35,000 award for his project titled, 'Targeted Noninvasive Brain Stimulation for Improving the Hand Dexterity in Stroke Patients.' Katie Lancaster, PhD, received a one-year $35,000 award for her project titled: 'A Social Emotion Regulation Intervention in Multiple Sclerosis.'
Source: EurekAlert! - Medicine and Health - June 21, 2019 Category: International Medicine & Public Health Source Type: news

New dimensions in the treatment of muscle spasticity after stroke and nervous system defects
(E ö tv ö s Lor á nd University (ELTE), Faculty of Science) Chronic muscle spasticity after nervous system defects like stroke, traumatic brain and spinal cord injury, multiple sclerosis and painful low back pain affect more than 10% of the population, with a socioeconomic cost of about 500 billion USD. Currently, there is no satisfying remedy to help these suffering people, which generates an immense medical need for a new generation antispastic drug. Drug candidate MPH-220 could mean new hope for millions of patients suffering from spasticity.
Source: EurekAlert! - Medicine and Health - October 16, 2020 Category: International Medicine & Public Health Source Type: news

Protocol for the development of a core outcome set for evaluating mixed-diagnosis falls prevention interventions for people with multiple sclerosis, Parkinson's disease and stroke - O'Malley N, Coote S, Clifford AM.
BACKGROUND: Given the high incidence of falls and their associated negative effects, the development of effective falls prevention interventions for people with Multiple Sclerosis (MS), Parkinson's Disease (PD) and stroke is a priority. Currently the imple...
Source: SafetyLit - June 6, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach
Conclusions: Some items performed differently between the three samples but did not bias person measures, thereby indicating that fatigue interference in these illnesses might still be reliably compared using FSS-7 scores. However, caution is warranted when comparing fatigue raw sum scores directly across diagnostic groups using the FSS-7. Further studies of the scale are needed in other types of chronic illnesses.
Source: Health and Quality of Life Outcomes - February 22, 2014 Category: Global & Universal Authors: Sverker JohanssonAnders KottorpKathryn LeeCaryl GayAnners Lerdal Source Type: research

Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012–2013
Conclusions: Neuropsychiatric disorders, including those traditionally considered outside the purview of refugee health, are an important burden to health among Iraqi and Syrian refugees. Possible interventions could include stroke risk factor reduction and targeted medication donations for multiple sclerosis, epilepsy, and schizophrenia.
Source: Conflict and Health - March 29, 2015 Category: Global & Universal Authors: Erica McKenziePaul SpiegelAdam KhalifaFarrah Mateen Source Type: research

POSB90 Healthcare Resource Utilization and Costs in Adult Patients with Spasticity: A Matched Cohort Analysis
Spasticity is abnormal muscle tightness due to muscle contraction associated with damage to the brain, spinal cord, or motor nerves, and is seen in individuals with neurological etiologies such as cerebral palsy (CP), multiple sclerosis (MS), stroke, or injuries to the central nervous system (CNS). Spasticity affects more than 12 million individuals worldwide. This analysis evaluated incremental healthcare resource utilization (HCRU) and costs in adult patients with spasticity and either CP, MS, stroke, or CNS injury (cases) versus a random sample of patients without spasticity (controls) over a 1-year period from a U.S.
Source: Value in Health - January 1, 2022 Category: International Medicine & Public Health Authors: M Hull, VR Anupindi, J He, N Danchenko, M DeKoven, J Bouchard Source Type: research

Epidemiology of neurologically disabling disorders - Tennant A.
Neurological disorders place a considerable burden upon individuals, their families, and society. Some like stroke are common, while others like amyotrophic lateral sclerosis are much rarer. Some conditions such as multiple sclerosis are reported to vary b...
Source: SafetyLit: All (Unduplicated) - January 18, 2013 Category: Global & Universal Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy - Kluger BM, Krupp LB, Enoka RM.
Fatigue is commonly reported in many neurologic illnesses, including multiple sclerosis, Parkinson disease, myasthenia gravis, traumatic brain injury, and stroke. Fatigue contributes substantially to decrements in quality of life and disability in these il...
Source: SafetyLit: All (Unduplicated) - January 25, 2013 Category: Global & Universal Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review
Conclusions: Incontinent patients with underlying neurologic conditions have impaired HRQoL as well as substantial economic burden attributable to UI due to NDO. There is a need for urgency UI treatments that improve HRQoL of these patients and alleviate the economic burden of this condition.
Source: Health and Quality of Life Outcomes - January 31, 2013 Category: Global & Universal Authors: Crisanta TapiaKristin KhalafKarina BerensonDenise GlobeMichael ChancellorLesley Carr Source Type: research

Kessler Foundation researchers share findings in rehabilitation research at AAN meeting in San Diego
(Kessler Foundation) Kessler Foundation scientists and their colleagues will discuss their progress in rehabilitation research in multiple sclerosis and stroke at the upcoming 65th Annual American Academy of Neurology Conference at the San Diego Convention Center in San Diego, CA, March 16 - 23.
Source: EurekAlert! - Social and Behavioral Science - March 15, 2013 Category: Global & Universal Source Type: news

Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS
Pseudobulbar Affect (PBA) is a neurologic disorder of emotional expression, resulting in frequent and involuntary episodes of crying and/or laughing. Common neurological conditions associated with PBA include: Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s disease, stroke and traumatic brain injury. Nuedexta® (Avanir Pharmaceuticals Inc. ) is the only EMA-approved PBA treatment. The financial impact of introducing Nuedexta to a national health care system, including Scotland, has never been formally estimated.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: C. Kiff, S. Mealing, M. Singh, S. Baculea, A. Badhan, C. Yonan Source Type: research

Tracking Healthcare Utilization (Cost) In Pseudobulbar affect Patients treated with Nuedexta
Pseudobulbar affect (PBA) is an underdiagnosed condition characterized by sudden, involuntary episodes of crying and/or laughing in patients with traumatic brain injury or certain neurologic diseases, including multiple sclerosis, amyotrophic lateral sclerosis, stroke, Alzheimer’s disease, and others. Studies suggest that PBA symptoms are associated with added healthcare utilization and costs. NUEDEXTA (dextromethorphan/quinidine) is the only FDA and EMA approved PBA treatment. The primary objective of this analysis is to evaluate healthcare utilization and costs in PBA patients before and after dextromethorphan/quinidine treatment.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: M Palmgren, A Cyhaniuk, C Yonan, E Potente Source Type: research

Wyss Institute collaborates with ReWalk Robotics to develop wearable exosuits
(Wyss Institute for Biologically Inspired Engineering at Harvard) The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities. The agreement with ReWalk will help speed the design of assistive exosuits that could help patients suffering from stroke and multiple sclerosis (MS) to regain mobility.
Source: EurekAlert! - Medicine and Health - May 17, 2016 Category: Global & Universal Source Type: news